GXCPC1

Gwo Xi Stem Cell Applied Technology Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	GXCPC1
Sponsor	Gwo Xi Stem Cell Applied Technology Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GXCPC1 CI brief — competitive landscape report
GXCPC1 updates RSS · CI watch RSS
Gwo Xi Stem Cell Applied Technology Co., Ltd. portfolio CI